A Aforeworn
Forewarned is forearmed.
Home › Niches › Pharmacy & Controlled Substances › Change
Low urgency

New DEA Rule Expected to Extend Controlled Substance Telemedicine Prescribing Flexibilities Through 2025 - The National Law Review

Detected August 24, 2026 · in Pharmacy & Controlled Substances

The DEA is expected to extend telemedicine prescribing flexibilities for controlled substances through 2025, maintaining current remote prescribing allowances.

Aforeworn detected this change in the Pharmacy & Controlled Substances space on August 24, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. Independent pharmacies, retail chains, compounding pharmacies, and long-term-care pharmacies that dispense controlled substances via telemedicine prescriptions. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Not specified; the rule is expected to extend through 2025.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.

What changed

The DEA is expected to extend current telemedicine prescribing flexibilities for controlled substances through 2025, meaning existing remote prescribing rules will continue.

Who it affects

Independent pharmacies, retail chains, compounding pharmacies, and long-term-care pharmacies that dispense controlled substances via telemedicine prescriptions.

What you must do

No immediate action required; continue operating under current telemedicine prescribing rules. Monitor for the final rule to confirm details.

Deadline

Not specified; the rule is expected to extend through 2025.

Source: https://news.google.com/rss/articles/CBMiqwFBVV95cUxNYmxwUFBqZnpSN3hILTFRR1RqNUMtOVVkUVJrbmxLTFZxeURGRzdvVFVNdWlmd09zSnRxOGc1N0tpVjhtTkFadFd5cXdFME5vQXhtV0pya1JjMFRTTEFBZklMTnlSb0lsU21fakJhSF9FVUpGTzA5bDVnZVRsSDNZOHlEdFI5UVdvSFVjT1JNbmp1dzVXN3pvbHBTY3FTb1FXc3VvdzBCc2ZOam_SAbABQVVfeXFMTXdjTkg4SVZ1QU9GMC1HWUF0eG5sSk9haDJkQTB4YUtjOV9kcnpfc3BtX1NPLVBMZjhBQ0JndFNNT094UzdSN2ZBRi1HYUtTWjZ2N2dqVC12d1hnMnNueDI3bDZyQTlzTHZMVWpnV25mU2M5RkNMam1DaWxJV0diUHBSQzZzX2FPR1hjNVZlN2RRemtIeEtBNGJHR0puYmdZSW1LSktTdlBnYThBWkVBeGY?oc=5

Never miss a change like this again

Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.

Start your free trial

Related changes in Pharmacy & Controlled Substances